261 related articles for article (PubMed ID: 32990355)
1. Mir-488 alleviates chemoresistance and glycolysis of colorectal cancer by targeting PFKFB3.
Deng X; Li D; Ke X; Wang Q; Yan S; Xue Y; Wang Q; Zheng H
J Clin Lab Anal; 2021 Jan; 35(1):e23578. PubMed ID: 32990355
[TBL] [Abstract][Full Text] [Related]
2. LncRNA XIST/miR-137 axis strengthens chemo-resistance and glycolysis of colorectal cancer cells by hindering transformation from PKM2 to PKM1.
Zheng H; Zhang M; Ke X; Deng X; Li D; Wang Q; Yan S; Xue Y; Wang Q
Cancer Biomark; 2021; 30(4):395-406. PubMed ID: 33386794
[TBL] [Abstract][Full Text] [Related]
3. Circular RNA sterile alpha motif domain containing 4A contributes to cell 5-fluorouracil resistance in colorectal cancer by regulating the miR-545-3p/6-phosphofructo-2-kinase/fructose-2,6-bisphosphataseisotype 3 axis.
Gao Y; Liu C; Xu X; Wang Y; Jiang Y
Anticancer Drugs; 2022 Jul; 33(6):553-563. PubMed ID: 35276696
[TBL] [Abstract][Full Text] [Related]
4. GDPD5, a target of miR-195-5p, is associated with metastasis and chemoresistance in colorectal cancer.
Feng C; Zhang L; Sun Y; Li X; Zhan L; Lou Y; Wang Y; Liu L; Zhang Y
Biomed Pharmacother; 2018 May; 101():945-952. PubMed ID: 29635904
[TBL] [Abstract][Full Text] [Related]
5. MiR
Lin Y; Wang W; Wang Y; Fu K
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2023 Mar; 48(3):356-368. PubMed ID: 37164919
[TBL] [Abstract][Full Text] [Related]
6. Circ_0014130 is involved in the drug sensitivity of colorectal cancer through miR-197-3p/PFKFB3 axis.
Wang W; Zhou L; Li Z; Lin G
J Gastroenterol Hepatol; 2022 May; 37(5):908-918. PubMed ID: 35288979
[TBL] [Abstract][Full Text] [Related]
7. Interleukin-6 stimulates aerobic glycolysis by regulating PFKFB3 at early stage of colorectal cancer.
Han J; Meng Q; Xi Q; Zhang Y; Zhuang Q; Han Y; Jiang Y; Ding Q; Wu G
Int J Oncol; 2016 Jan; 48(1):215-24. PubMed ID: 26530697
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of miR-206 suppresses glycolysis, proliferation and migration in breast cancer cells via PFKFB3 targeting.
Ge X; Lyu P; Cao Z; Li J; Guo G; Xia W; Gu Y
Biochem Biophys Res Commun; 2015 Aug; 463(4):1115-21. PubMed ID: 26093295
[TBL] [Abstract][Full Text] [Related]
9. The lncRNA XIST/miR-125b-2-3p axis modulates cell proliferation and chemotherapeutic sensitivity via targeting Wee1 in colorectal cancer.
Zeng ZL; Lu JH; Wang Y; Sheng H; Wang YN; Chen ZH; Wu QN; Zheng JB; Chen YX; Yang DD; Yu K; Mo HY; Hu JJ; Hu PS; Liu ZX; Ju HQ; Xu RH
Cancer Med; 2021 Apr; 10(7):2423-2441. PubMed ID: 33666372
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-488 inhibits proliferation and glycolysis in human prostate cancer cells by regulating PFKFB3.
Wang J; Li X; Xiao Z; Wang Y; Han Y; Li J; Zhu W; Leng Q; Wen Y; Wen X
FEBS Open Bio; 2019 Oct; 9(10):1798-1807. PubMed ID: 31410981
[TBL] [Abstract][Full Text] [Related]
11. miR-193a-5p as a promising therapeutic candidate in colorectal cancer by reducing 5-FU and Oxaliplatin chemoresistance by targeting CXCR4.
Azar MRMH; Aghazadeh H; Mohammed HN; Sara MRS; Hosseini A; Shomali N; Tamjidifar R; Tarzi S; Mansouri M; Sarand SP; Marofi F; Akbari M; Xu H; Shotorbani SS
Int Immunopharmacol; 2021 Mar; 92():107355. PubMed ID: 33429333
[TBL] [Abstract][Full Text] [Related]
12. Regulatory effects of lncRNA ATB targeting miR-200c on proliferation and apoptosis of colorectal cancer cells.
Gao Z; Zhou H; Wang Y; Chen J; Ou Y
J Cell Biochem; 2020 Jan; 121(1):332-343. PubMed ID: 31222825
[TBL] [Abstract][Full Text] [Related]
13. EVs delivery of miR-1915-3p improves the chemotherapeutic efficacy of oxaliplatin in colorectal cancer.
Xiao Z; Liu Y; Li Q; Liu Q; Liu Y; Luo Y; Wei S
Cancer Chemother Pharmacol; 2021 Dec; 88(6):1021-1031. PubMed ID: 34599680
[TBL] [Abstract][Full Text] [Related]
14. Glycolysis is essential for chemoresistance induced by transient receptor potential channel C5 in colorectal cancer.
Wang T; Ning K; Sun X; Zhang C; Jin LF; Hua D
BMC Cancer; 2018 Feb; 18(1):207. PubMed ID: 29463225
[TBL] [Abstract][Full Text] [Related]
15. Targeting of PFKFB3 with miR-206 but not mir-26b inhibits ovarian cancer cell proliferation and migration involving FAK downregulation.
Boscaro C; Baggio C; Carotti M; Sandonà D; Trevisi L; Cignarella A; Bolego C
FASEB J; 2022 Mar; 36(3):e22140. PubMed ID: 35107852
[TBL] [Abstract][Full Text] [Related]
16. circHIPK3 promotes oxaliplatin-resistance in colorectal cancer through autophagy by sponging miR-637.
Zhang Y; Li C; Liu X; Wang Y; Zhao R; Yang Y; Zheng X; Zhang Y; Zhang X
EBioMedicine; 2019 Oct; 48():277-288. PubMed ID: 31631038
[TBL] [Abstract][Full Text] [Related]
17. KLF9 (Kruppel Like Factor 9) induced PFKFB3 (6-Phosphofructo-2-Kinase/Fructose-2, 6-Biphosphatase 3) downregulation inhibits the proliferation, metastasis and aerobic glycolysis of cutaneous squamous cell carcinoma cells.
Xing J; Jia Z; Xu Y; Chen M; Yang Z; Chen Y; Han Y
Bioengineered; 2021 Dec; 12(1):7563-7576. PubMed ID: 34612136
[TBL] [Abstract][Full Text] [Related]
18. Exosome-delivered circRNA promotes glycolysis to induce chemoresistance through the miR-122-PKM2 axis in colorectal cancer.
Wang X; Zhang H; Yang H; Bai M; Ning T; Deng T; Liu R; Fan Q; Zhu K; Li J; Zhan Y; Ying G; Ba Y
Mol Oncol; 2020 Mar; 14(3):539-555. PubMed ID: 31901148
[TBL] [Abstract][Full Text] [Related]
19. LncRNA XIST facilitates proliferation and epithelial-mesenchymal transition of colorectal cancer cells through targeting miR-486-5p and promoting neuropilin-2.
Liu A; Liu L; Lu H
J Cell Physiol; 2019 Aug; 234(8):13747-13761. PubMed ID: 30656681
[TBL] [Abstract][Full Text] [Related]
20. Upregulation of microRNA-135b and microRNA-182 promotes chemoresistance of colorectal cancer by targeting ST6GALNAC2 via PI3K/AKT pathway.
Liu B; Liu Y; Zhao L; Pan Y; Shan Y; Li Y; Jia L
Mol Carcinog; 2017 Dec; 56(12):2669-2680. PubMed ID: 28767179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
